Amlashi Seyed F A, Riffaud Laurent, Brassier Gilles, Morandi Xavier
Service de Neurochirurgie, Hôpital Pontchaillou, Rennes, France.
Cancer. 2003 Aug 1;98(3):618-24. doi: 10.1002/cncr.11537.
Patients with nevoid basal cell carcinoma syndrome (NBCCS) are believed to be predisposed to develop early-onset neoplasms including medulloblastomas (MB). The desmoplastic subtype of MB is associated most commonly with NBCCS. The goals of this study were to demonstrate the relation between desmoplastic MB and NBCCS and to evaluate the concomitant diagnosis of NBCCS and MB.
The medical records of 76 consecutive children who received surgical treatment for MB between 1970 and 2000 were studied. A review of the literature was performed based on the National Library of Medicine database and bibliographies of selected articles were scanned.
The authors reported three patients with NBCCS who received surgical treatment for an MB during infancy. The literature review identified 33 patients with NBCCS who were treated for MB at a mean age of 28 months. The desmoplastic subtype was the only histopathologic subtype of MB reported in the NBCCS population. Although patients with NBCCS are predisposed to develop multiple basal cell carcinomas and intracranial tumors in the field of irradiation, the prognosis for syndromic MBs was much better compared with the prognosis for sporadic MBs.
Patients with NBCCS have an increased risk for other malignancies, especially radiation-induced neoplasms. Early diagnosis of this syndrome is important for the selection of appropriate adjuvant treatment and family genetic counseling. The authors did not advocate the use of radiotherapy as an adjuvant treatment in desmoplastic MB diagnosed in children younger than 5 years of age. They suggested that the desmoplastic subtype of MB in children younger than 2 years of age is a major diagnostic criterion for the diagnosis of NBCCS.
痣样基底细胞癌综合征(NBCCS)患者被认为易患早发性肿瘤,包括髓母细胞瘤(MB)。MB的促结缔组织增生型最常与NBCCS相关。本研究的目的是证明促结缔组织增生型MB与NBCCS之间的关系,并评估NBCCS和MB的联合诊断。
研究了1970年至2000年间连续接受MB手术治疗的76例儿童的病历。基于美国国立医学图书馆数据库进行文献综述,并扫描所选文章的参考文献目录。
作者报告了3例NBCCS患者,他们在婴儿期接受了MB手术治疗。文献综述确定了33例NBCCS患者,他们接受MB治疗的平均年龄为28个月。促结缔组织增生型是NBCCS人群中报告的MB唯一组织病理学亚型。尽管NBCCS患者易患多个基底细胞癌和放疗区域内的颅内肿瘤,但综合征性MB的预后比散发性MB的预后要好得多。
NBCCS患者发生其他恶性肿瘤的风险增加,尤其是辐射诱发的肿瘤。该综合征的早期诊断对于选择合适的辅助治疗和家庭遗传咨询很重要。作者不主张对5岁以下儿童诊断出的促结缔组织增生型MB使用放疗作为辅助治疗。他们建议2岁以下儿童的促结缔组织增生型MB是诊断NBCCS的主要诊断标准。